P/E ratio for Ekso Bionics (EKSO)
P/E ratio as of June 2024 (TTM): -0.9018
According to Ekso Bionics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.901786. At the end of 2022 the company had a P/E ratio of -1.03.
P/E ratio history for Ekso Bionics from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.03 | -68.26% |
| 2021 | -3.23 | 30.74% |
| 2020 | -2.47 | 14.63% |
| 2019 | -2.16 | -23.49% |
| 2018 | -2.82 | 23.02% |
| 2017 | -2.29 | -2.13% |
| 2016 | -2.34 | -58.25% |
| 2015 | -5.61 | 84.55% |
| 2014 | -3.04 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 STAAR Surgical STAA | 101 | -11,273.60% | 🇺🇸 USA |
 OraSure Technologies OSUR | 7.28 | -906.83% | 🇺🇸 USA |
 AtriCure ATRC | -39.4 | 4,269.93% | 🇺🇸 USA |
 Biolase
BIOL | -0.0003 | -99.97% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.